Among patients who took at least two doses of medication, GLP-1 receptor agonists were associated with a significantly lower ...

New study questions benefits of GLP-1 drugs for weight loss, finding high costs with little long-term health benefit. Read ...

While the regulator has not approved their use in type 1 diabetes, off-label prescribing for GLP-1 receptor agonists has ...

To add more protein to your life, you can consider adding animal proteins like eggs, cottage cheese, Greek yogurt, and ...

For GLP-1 treatment in particular, employers “need to make sure the coverage is married with a patient engagement program, ...

Companies are figuring out how to cater to consumers using GLP-1 drugs, such as Ozempic.

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...

An analysis of over 400,000 patients with T1D revealed a rise in prescribing for glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors over the past decade.

Semaglutide (Ozempic) was tied to a reduced risk of Alzheimer's disease diagnoses in people with type 2 diabetes, ...

Laks Pernenkil, Brian Feth, and Alex Philippidis go behind the headlines to discuss the impact of recent news, including ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...